biotech.quantcalc.app

What the filings say, before the readout.

Dated flag sheets for Phase 3 biotech names, built from SEC filings, the trial registry and the FDA label index. Each statement cites its document. Calls are scored when the event resolves, and misses stay on the board.

29 sheets 11 calls0 confirmed 0 refuted11 pending

Upcoming readouts

OCGN · Ocugen Inc
readout 2026-09-28 · published 2026-09-02
Stargardt Disease · 13 statements
BHVN · Biohaven Ltd
readout 2026-10-01 · published 2026-09-02
Focal Epilepsy · 8 statements
CLDX · Celldex Therapeutics Inc
readout 2026-10-01 · published 2026-09-02
Chronic Inducible Urticaria · 6 statements
ANNX · Annexon Inc
readout 2026-10-31 · published 2026-09-02
Geographic Atrophy · 7 statements
OLMA · Olema Pharmaceuticals Inc
readout 2026-10-31 · published 2026-09-02
Breast Cancer · 10 statements
SRPT · Sarepta Therapeutics Inc
readout 2026-10-31 · published 2026-09-02
Muscular Dystrophy, Duchenne · 6 statements
TGTX · Tg Therapeutics Inc
readout 2026-10-31 · published 2026-09-02
Relapsing Multiple Sclerosis · 7 statements
CAPR · Capricor Therapeutics Inc
readout 2026-11-22 · published 2026-09-02
Muscular Dystrophies · 11 statements
CMPX · Compass Therapeutics Inc
readout 2026-12-01 · published 2026-09-02
Biliary Tract Cancer · 9 statements
VIR · Vir Biotechnology Inc
readout 2026-12-01 · published 2026-09-02
Viral Hepatitis · 7 statements
IDYA · Ideaya Biosciences Inc
readout 2027-01-15 · published 2026-09-02
Uveal Melanoma · 8 statements
KOD · Kodiak Sciences Inc
readout 2027-02-01 · published 2026-09-02
Macular Edema Secondary to Inflammation · 7 statements
Don't see a name? Request a sheet. Any US-listed biotech with a Phase 3 or a pending FDA decision — it gets built the same way, from the filings.

Scoreboard

NameCallPublishedResolvesOutcome
RGNXRaises capital within four quarters of 2026-09-02 (runway 2.5q)2026-09-022026-09-01pending
BHVNRaises capital within four quarters of 2026-09-02 (runway 1.7q)2026-09-022026-10-01pending
ANNXRaises capital within four quarters of 2026-09-02 (runway 3.9q)2026-09-022026-10-31pending
CAPRRaises capital within four quarters of 2026-09-02 (runway 3.0q)2026-09-022026-11-22pending
KODRaises capital within four quarters of 2026-09-02 (runway 2.1q)2026-09-022027-02-01pending
VORRaises capital before the 2027-05-01 readout (runway 2.0q)2026-09-022027-05-01pending
IOVARaises capital before the 2028-03-01 readout (runway 3.5q)2026-09-022028-03-01pending
CABARaises capital before the 2028-07-01 readout (runway 4.8q)2026-09-022028-07-01pending
VSTMRaises capital within four quarters of 2026-09-02 (runway 3.8q)2026-09-022028-10-15pending
REPLRaises capital within four quarters of 2026-09-02 (runway 2.5q)2026-09-022030-01-01pending
BCRXRaises capital within four quarters of 2026-09-02 (runway 2.6q)2026-09-022031-08-01pending
A call is a statement resolved by a future event: that the company raises capital before its registered primary completion, or within four quarters when its runway is that short. A fact is verifiable against its cited document today and is not scored. Sheets are never edited after publication.